Healthcare Value in a Consumer-Oriented, Patient-Centric Era
A Healthcare Executive Roundtable Discussion
New York, NY, USA
New York, NY, USA
The Center for Healthcare Innovation’s 5th annual Healthcare Executive Roundtable is an intimate, invitation-only, expert roundtable discussion for healthcare executives, key opinion leaders, and patient groups to discuss how stakeholders throughout the healthcare ecosystem can address critical issues related to healthcare value, quality, and cost. The Roundtable will focus on several key market forces that affect the current state of healthcare in the U.S.
One pressing issue that has dominated headlines over the past 18 months is drug pricing. Total drug spending in the U.S. increased by 8.5% in 2016 and is expected to reach $400 billion by 2020. Nearly 90% of drugs dispensed are generics, yet cost and value for medications remain a significant burden for patients. While increased spending has put a strain on public and private payers, the value of prescription drugs has come to the forefront of national attention. In fact, in a recent study, 60% of Americans identified lowering the cost of prescription drugs as a top priority, and 87% favored improving the ease with which generic drugs could come to market. And according to the Edelman Trust Barometer, trust in the pharmaceutical industry is extremely low.
Additionally, the pace of the shift from volume-to-value continues to impact healthcare. In 2014, 90% of payers and 81% of providers were already using some form of value-based purchasing. The heightened attention to value in healthcare also necessitates an increased focus on patient engagement. More informed, empowered patients are acting as consumers for their care and medications, and healthcare stakeholders need to tailor their approaches to better engage patients. Patients who are engaged in their own care have been shown to have better outcomes, and lead to lower costs for the health system.
Finally, these changes come against a backdrop of changes in the political landscape and potential large-scale policy changes. This creates uncertainty for all healthcare stakeholder—providers, payers, patients, biopharma, and policy makers. The fate of the Affordable Care Act and the American Health Care Act will undoubtedly affect stakeholders throughout the healthcare ecosystem. Healthcare professionals and patients will need to tailor their approaches to the new, rapidly shifting healthcare environment.
The Center for Healthcare Innovation’s “Understanding Value in a Consumer-Oriented, Patient-Centric Era” Roundtable on October 12, 2017, in Manhattan is an expert, cross-sectoral collaborative discussion that will provide a forum for healthcare executives to discuss these issues and optimize engagement, communication, and collaboration. The exclusive, limited-attendance roundtable is designed to provide the top thought leaders with the latest insights and ideas on healthcare value, quality, and cost. To improve healthcare, disparate sectors must come together to have meaningful, informed dialogues about the nuances of healthcare value, and must do so in a way that fosters multi-dimensional co-learning.
more about how other healthcare organizations and patients are responding to uncertainty and potential large-scale policy changes that may dramatically impact stakeholders throughout the healthcare ecosystem
an intimate, invitation-only, expert roundtable discussion about how stakeholders throughout the healthcare ecosystem can address critical healthcare issues – including value, quality, and cost
how generic drugs affect cost, access, and value of treatments for patients
how the heightened attention to value in healthcare also necessitates an increased focus on patient engagement
a meaningful, informed dialogue around the complex drug pricing arena, and the concerns and viewpoints of stakeholder groups that have sometimes opposing perspectives, including patients, pharma, payers, and providers
with senior healthcare executives and key opinion leaders from the provider, payer, pharma, and patient sectors
on several key market forces that affect the current state of healthcare in the U.S.
knowledge on the trends, challenges, and opportunities of the shift from volume to value
Mr. Quentin Roach, MSMerck
Mr. Robert CoullGPIC
Mr. Noah TolsonArray Architects
Mr. Fred Nazem, MBARejuvenan
Mr. Benjamin GregoryBest Practices
Mr. Joe Camaratta, MSQuantitative Radiology Solutions
Dr. Nathalie Horowicz-Mehler, PhDQuintilesIMS
Dr. Falguni Sen, PhDFordham University
Ms. Erica Ahmed, MA, MSThe Scientific Consulting Group
Dr. Airica Steed, EdD, MBA, RNPresence Health
Dr. Anand Iyer, PhD, MBAWellDoc
Dr. Rivka Riven Kreitman, PhDTeva Pharmaceuticals
Dr. William Carson, MDOtsuka Pharmaceutical Development & Commercialization
Ms. Vera Rulon, MSTir Health Advisors
Mr. Ken BantaThe Vanguard Group For Leadership
Mr. Anthony ChambersWest Monroe Partners
Mr. Joseph GasperoCenter for Healthcare Innovation
Dr. Cheryl Beal Anderson, PharmD, MBAUpsherSmith Laboratories
Mr. Mitchell DeKoven, MHSAQuintilesIMS
Ms. Lynn HanessianEdelman
Mr. Joff MasukawaDiligentia
New York, NY, USA
Please contact us with any symposium questions.